JP Stock MarketDetailed Quotes

Shin Nippon Biomedical Laboratories (2395)

Watchlist

1220
+37+3.13%

20min DelayMarket Closed May 15 15:30 JST

50.79BMarket Cap11.12P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shin Nippon Biomedical Laboratories (2395) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2026

(Q1)Jun 30, 2025

(FY)Mar 31, 2025

(Q1)Jun 30, 2024

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

Total revenue

0.34%32.52B

16.72%6.48B

22.55%32.41B

-4.40%5.55B

5.42%26.45B

8.47B

1.29%6.1B

-3.54%6.08B

43.46%5.8B

41.37%25.09B

Cost of revenue

5.39%16.29B

35.00%3.41B

27.00%15.45B

-3.31%2.52B

1.03%12.17B

3.72B

4.87%2.92B

-1.09%2.92B

31.11%2.61B

49.41%12.04B

Gross profit

-4.26%16.24B

1.47%3.07B

18.75%16.96B

-5.29%3.02B

9.47%14.28B

4.75B

-1.78%3.18B

-5.70%3.16B

55.42%3.19B

34.68%13.05B

Operating expense

-2.80%13.58B

7.58%3.41B

38.10%13.98B

61.18%3.17B

29.72%10.12B

3.12B

69.23%3B

16.36%2.04B

46.67%1.97B

42.06%7.8B

Staff costs

7.86%4.62B

----

31.34%4.28B

----

12.55%3.26B

----

19.75%2.9B

Selling and administrative expenses

-7.71%2.08B

----

16.42%2.25B

----

43.25%1.93B

----

34.74%1.35B

-General and administrative expense

-7.71%2.08B

----

16.42%2.25B

----

43.25%1.93B

----

34.74%1.35B

Research and development costs

8.24%2.4B

----

27.37%2.22B

----

154.91%1.74B

----

60.69%683.07M

Depreciation and amortization

5.63%411.94M

----

49.20%389.97M

----

16.33%261.37M

----

41.34%224.68M

-Depreciation

5.63%411.94M

----

49.20%389.97M

----

16.33%261.37M

----

41.34%224.68M

Rent and land expenses

12.11%233.86M

----

30.55%208.6M

----

16.50%159.78M

----

31.27%137.15M

Other operating expenses

-16.93%3.85B

----

67.32%4.63B

----

10.14%2.77B

----

81.49%2.51B

Operating profit

-11.10%2.65B

-134.82%-340.94M

-28.28%2.99B

-111.83%-145.19M

-20.64%4.16B

1.63B

-87.33%186.25M

-29.84%1.12B

71.86%1.23B

25.02%5.25B

Net non-operating interest income (expenses)

47.50%-55.39M

-33.71%-51.15M

-320.86%-105.52M

-4.93%-38.26M

170.61%47.78M

68.84M

-50.24%-43.76M

451.54%59.16M

-30.92%-36.46M

42.82%-67.66M

Non-operating interest income

144.60%237.83M

190.03%6.66M

-47.88%97.23M

373.61%2.3M

225.01%186.56M

--110.76M

-5,042.78%-9.59M

438.05%84.9M

-33.01%485K

590.50%57.4M

Non-operating interest expense

44.62%293.22M

42.56%57.82M

46.09%202.75M

9.77%40.56M

10.97%138.78M

--41.92M

16.54%34.17M

-21.04%25.75M

29.30%36.95M

-1.25%125.06M

Net investment income

196.00%154.63M

143.11%121.51M

-357.97%-161.07M

-197.20%-281.88M

-95.87%62.44M

-219.2M

102.69%37.73M

-105.12%-46.09M

-82.81%289.99M

10.34%1.51B

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

97.97%-3M

-371.86%-147.96M

97.70%-31.36M

-31.36M

-3,554.64%-1.36B

Income from associates and other participating interests

-21.25%2.78B

-5.65%725.58M

28.29%3.53B

44.58%768.99M

10.55%2.75B

603.65M

4.25%908.31M

-5.10%707.97M

44.93%531.88M

41.29%2.49B

Special income (charges)

-24.63%-382.52M

-487.39%-182.25M

-2,932.64%-306.93M

-148.49%-31.03M

86.22%-10.12M

-63.52M

65.03%-3.97M

-119.02%-6.62M

14,510.81%63.98M

-108.95%-73.42M

Less:Restructuring and mergern&acquisition

----

--0

---82.16M

--0

---82.16M

--0

Less:Other special charges

62.12%370.93M

488.49%176.03M

296.84%228.8M

85.41%29.91M

98.36%57.66M

--32.75M

-71.16%3.27M

115.80%5.5M

9,266.48%16.13M

102.78%29.07M

Less:Write off

-85.16%11.6M

457.76%6.22M

125.63%78.13M

-45.53%1.12M

-21.93%34.63M

--30.77M

--695K

--1.12M

230.16%2.05M

-80.30%44.36M

Other non-operating income (expenses)

401.91%1.1B

58.00%60.75M

2,691.11%219.1M

128.46%38.45M

-155.60%-8.46M

51.75M

-0.65%39.27M

149.33%35.63M

-522.62%-135.11M

-92.04%15.21M

Income before tax

3.90%6.25B

7.20%333.5M

-13.78%6.01B

-83.98%311.09M

-10.12%6.97B

2.04B

533.62%1.12B

-39.94%1.87B

-29.96%1.94B

-5.18%7.76B

Income tax

49.18%1.71B

-60.85%77M

-21.16%1.15B

-64.87%196.68M

-14.76%1.46B

323.82M

235.19%292.54M

-57.30%280.49M

-32.97%559.88M

68.17%1.71B

Net income

-6.79%4.53B

124.20%256.5M

-11.84%4.86B

-91.72%114.41M

-8.81%5.52B

1.71B

2,043.06%831.3M

-35.31%1.59B

-28.67%1.38B

-15.58%6.05B

Net income continuous operations

-6.79%4.53B

124.20%256.5M

-11.84%4.86B

-91.72%114.41M

-8.81%5.52B

--1.71B

2,043.01%831.3M

-35.31%1.59B

-28.67%1.38B

-15.58%6.05B

Noncontrolling interests

46.07%-32.5M

49.60%-3.92M

-344.61%-60.26M

-195.18%-7.79M

-44.98%-13.55M

-23.65M

-88.85%2.82M

93.81%-898K

206.47%8.18M

-123.68%-9.35M

Net income attributable to the company

-7.27%4.57B

113.13%260.43M

-10.96%4.92B

-91.10%122.19M

-8.73%5.53B

1.74B

1,317.10%828.48M

-35.65%1.59B

-29.37%1.37B

-14.98%6.06B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-7.27%4.57B

113.13%260.43M

-10.96%4.92B

-91.10%122.19M

-8.73%5.53B

1.74B

1,317.10%828.48M

-35.65%1.59B

-29.37%1.37B

-14.98%6.06B

Gross dividend payment

Basic earnings per share

-7.27%109.69

113.31%6.25

-10.97%118.29

-91.12%2.93

-8.72%132.86

41.72

1,313.41%19.9

-35.65%38.26

-29.38%32.98

-14.98%145.56

Diluted earnings per share

-7.27%109.69

113.31%6.25

-10.97%118.29

-91.12%2.93

-8.72%132.86

41.7135

1,313.41%19.9

-35.65%38.26

-29.38%32.98

-14.98%145.56

Dividend per share

0.00%50

0.00%20

66.67%50

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Mar 31, 2026	(Q1)Jun 30, 2025	(FY)Mar 31, 2025	(Q1)Jun 30, 2024	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023
Total revenue	0.34%32.52B	16.72%6.48B	22.55%32.41B	-4.40%5.55B	5.42%26.45B	8.47B	1.29%6.1B	-3.54%6.08B	43.46%5.8B	41.37%25.09B
Cost of revenue	5.39%16.29B	35.00%3.41B	27.00%15.45B	-3.31%2.52B	1.03%12.17B	3.72B	4.87%2.92B	-1.09%2.92B	31.11%2.61B	49.41%12.04B
Gross profit	-4.26%16.24B	1.47%3.07B	18.75%16.96B	-5.29%3.02B	9.47%14.28B	4.75B	-1.78%3.18B	-5.70%3.16B	55.42%3.19B	34.68%13.05B
Operating expense	-2.80%13.58B	7.58%3.41B	38.10%13.98B	61.18%3.17B	29.72%10.12B	3.12B	69.23%3B	16.36%2.04B	46.67%1.97B	42.06%7.8B
Staff costs	7.86%4.62B	----	31.34%4.28B	----	12.55%3.26B	----	----	----	----	19.75%2.9B
Selling and administrative expenses	-7.71%2.08B	----	16.42%2.25B	----	43.25%1.93B	----	----	----	----	34.74%1.35B
-General and administrative expense	-7.71%2.08B	----	16.42%2.25B	----	43.25%1.93B	----	----	----	----	34.74%1.35B
Research and development costs	8.24%2.4B	----	27.37%2.22B	----	154.91%1.74B	----	----	----	----	60.69%683.07M
Depreciation and amortization	5.63%411.94M	----	49.20%389.97M	----	16.33%261.37M	----	----	----	----	41.34%224.68M
-Depreciation	5.63%411.94M	----	49.20%389.97M	----	16.33%261.37M	----	----	----	----	41.34%224.68M
Rent and land expenses	12.11%233.86M	----	30.55%208.6M	----	16.50%159.78M	----	----	----	----	31.27%137.15M
Other operating expenses	-16.93%3.85B	----	67.32%4.63B	----	10.14%2.77B	----	----	----	----	81.49%2.51B
Operating profit	-11.10%2.65B	-134.82%-340.94M	-28.28%2.99B	-111.83%-145.19M	-20.64%4.16B	1.63B	-87.33%186.25M	-29.84%1.12B	71.86%1.23B	25.02%5.25B
Net non-operating interest income (expenses)	47.50%-55.39M	-33.71%-51.15M	-320.86%-105.52M	-4.93%-38.26M	170.61%47.78M	68.84M	-50.24%-43.76M	451.54%59.16M	-30.92%-36.46M	42.82%-67.66M
Non-operating interest income	144.60%237.83M	190.03%6.66M	-47.88%97.23M	373.61%2.3M	225.01%186.56M	--110.76M	-5,042.78%-9.59M	438.05%84.9M	-33.01%485K	590.50%57.4M
Non-operating interest expense	44.62%293.22M	42.56%57.82M	46.09%202.75M	9.77%40.56M	10.97%138.78M	--41.92M	16.54%34.17M	-21.04%25.75M	29.30%36.95M	-1.25%125.06M
Net investment income	196.00%154.63M	143.11%121.51M	-357.97%-161.07M	-197.20%-281.88M	-95.87%62.44M	-219.2M	102.69%37.73M	-105.12%-46.09M	-82.81%289.99M	10.34%1.51B
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets	97.97%-3M		-371.86%-147.96M		97.70%-31.36M	-31.36M	0			-3,554.64%-1.36B
Income from associates and other participating interests	-21.25%2.78B	-5.65%725.58M	28.29%3.53B	44.58%768.99M	10.55%2.75B	603.65M	4.25%908.31M	-5.10%707.97M	44.93%531.88M	41.29%2.49B
Special income (charges)	-24.63%-382.52M	-487.39%-182.25M	-2,932.64%-306.93M	-148.49%-31.03M	86.22%-10.12M	-63.52M	65.03%-3.97M	-119.02%-6.62M	14,510.81%63.98M	-108.95%-73.42M
Less:Restructuring and mergern&acquisition	----	----	--0	--0	---82.16M	--0	--0	--0	---82.16M	--0
Less:Other special charges	62.12%370.93M	488.49%176.03M	296.84%228.8M	85.41%29.91M	98.36%57.66M	--32.75M	-71.16%3.27M	115.80%5.5M	9,266.48%16.13M	102.78%29.07M
Less:Write off	-85.16%11.6M	457.76%6.22M	125.63%78.13M	-45.53%1.12M	-21.93%34.63M	--30.77M	--695K	--1.12M	230.16%2.05M	-80.30%44.36M
Other non-operating income (expenses)	401.91%1.1B	58.00%60.75M	2,691.11%219.1M	128.46%38.45M	-155.60%-8.46M	51.75M	-0.65%39.27M	149.33%35.63M	-522.62%-135.11M	-92.04%15.21M
Income before tax	3.90%6.25B	7.20%333.5M	-13.78%6.01B	-83.98%311.09M	-10.12%6.97B	2.04B	533.62%1.12B	-39.94%1.87B	-29.96%1.94B	-5.18%7.76B
Income tax	49.18%1.71B	-60.85%77M	-21.16%1.15B	-64.87%196.68M	-14.76%1.46B	323.82M	235.19%292.54M	-57.30%280.49M	-32.97%559.88M	68.17%1.71B
Net income	-6.79%4.53B	124.20%256.5M	-11.84%4.86B	-91.72%114.41M	-8.81%5.52B	1.71B	2,043.06%831.3M	-35.31%1.59B	-28.67%1.38B	-15.58%6.05B
Net income continuous operations	-6.79%4.53B	124.20%256.5M	-11.84%4.86B	-91.72%114.41M	-8.81%5.52B	--1.71B	2,043.01%831.3M	-35.31%1.59B	-28.67%1.38B	-15.58%6.05B
Noncontrolling interests	46.07%-32.5M	49.60%-3.92M	-344.61%-60.26M	-195.18%-7.79M	-44.98%-13.55M	-23.65M	-88.85%2.82M	93.81%-898K	206.47%8.18M	-123.68%-9.35M
Net income attributable to the company	-7.27%4.57B	113.13%260.43M	-10.96%4.92B	-91.10%122.19M	-8.73%5.53B	1.74B	1,317.10%828.48M	-35.65%1.59B	-29.37%1.37B	-14.98%6.06B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-7.27%4.57B	113.13%260.43M	-10.96%4.92B	-91.10%122.19M	-8.73%5.53B	1.74B	1,317.10%828.48M	-35.65%1.59B	-29.37%1.37B	-14.98%6.06B
Gross dividend payment
Basic earnings per share	-7.27%109.69	113.31%6.25	-10.97%118.29	-91.12%2.93	-8.72%132.86	41.72	1,313.41%19.9	-35.65%38.26	-29.38%32.98	-14.98%145.56
Diluted earnings per share	-7.27%109.69	113.31%6.25	-10.97%118.29	-91.12%2.93	-8.72%132.86	41.7135	1,313.41%19.9	-35.65%38.26	-29.38%32.98	-14.98%145.56
Dividend per share	0.00%50	0	0.00%50	0	0.00%50	30	0	0.00%20	0	66.67%50
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm